Reaction
Bladder Discomfort reporting signals
As of the last recalculation, Bladder Discomfort appears in 1,213 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is VIBEGRON (PRR 19.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Vibegron | 9 | 19.4 | 19.4 |
| Mirabegron | 36 | 16.4 | 16.4 |
| Fesoterodine Fumarate | 10 | 16.0 | 16.0 |
| Ciclesonide | 12 | 15.3 | 15.3 |
| Tolterodine Tartrate | 7 | 13.5 | 13.5 |
| Inclisiran | 4 | 8.6 | 8.6 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 4 | 8.1 | 8.1 |
| Vilazodone Hydrochloride | 4 | 7.5 | 7.5 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 6 | 6.2 | 6.2 |
| Teriflunomide | 16 | 6.1 | 6.1 |
| Siponimod | 3 | 5.8 | 5.8 |
| Ofatumumab | 10 | 5.2 | 5.2 |
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 3 | 4.9 | 4.9 |
| Dalfampridine | 18 | 4.4 | 4.4 |
| Alirocumab | 6 | 4.1 | 4.1 |
| Copper | 5 | 2.0 | 2.0 |